| Literature DB >> 35201268 |
Eszter Császár1,2, Nikolett Lénárt1, Csaba Cserép1, Zsuzsanna Környei1, Rebeka Fekete1, Balázs Pósfai1,2, Diána Balázsfi3, Balázs Hangya3, Anett D Schwarcz1, Eszter Szabadits1, Dávid Szöllősi4, Krisztián Szigeti4, Domokos Máthé5, Brian L West6, Katalin Sviatkó3, Ana Rita Brás1,2, Jean-Charles Mariani7, Andrea Kliewer7, Zsolt Lenkei7, László Hricisák8, Zoltán Benyó8, Mária Baranyi9, Beáta Sperlágh9, Ákos Menyhárt10,11, Eszter Farkas10,12, Ádám Dénes1.
Abstract
Microglia, the main immunocompetent cells of the brain, regulate neuronal function, but their contribution to cerebral blood flow (CBF) regulation has remained elusive. Here, we identify microglia as important modulators of CBF both under physiological conditions and during hypoperfusion. Microglia establish direct, dynamic purinergic contacts with cells in the neurovascular unit that shape CBF in both mice and humans. Surprisingly, the absence of microglia or blockade of microglial P2Y12 receptor (P2Y12R) substantially impairs neurovascular coupling in mice, which is reiterated by chemogenetically induced microglial dysfunction associated with impaired ATP sensitivity. Hypercapnia induces rapid microglial calcium changes, P2Y12R-mediated formation of perivascular phylopodia, and microglial adenosine production, while depletion of microglia reduces brain pH and impairs hypercapnia-induced vasodilation. Microglial actions modulate vascular cyclic GMP levels but are partially independent of nitric oxide. Finally, microglial dysfunction markedly impairs P2Y12R-mediated cerebrovascular adaptation to common carotid artery occlusion resulting in hypoperfusion. Thus, our data reveal a previously unrecognized role for microglia in CBF regulation, with broad implications for common neurological diseases.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35201268 PMCID: PMC8932534 DOI: 10.1084/jem.20211071
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 14.307